1920. Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX.
Kim MJ, Han SW, Lee DW, Cha Y, Lee KH, Kim TY, Oh DY, Kim SH, Im SA, Bang YJ, Kim TY.
Cancer Res Treat. 2016 Jul;48(3):990-7. doi: 10.4143/crt.2015.296. Epub 2016 Jan 14.Link
1919. Plasmablastic lymphoma exclusively involving bones mimicking osteosarcoma in an immunocompetent patient: A case report.
Sarker AK, Im HJ, Paeng JC, Cheon GJ, Kang KW, Chung JK, Lee DS.
Medicine (Baltimore). 2016 Jul;95(28):e4241. doi: 10.1097/MD.0000000000004241.Link
1918. Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
Lee SH, Ha S, An HJ, Lee JS, Han W, Im SA, Ryu HS, Kim WH, Chang JM, Cho N, Moon WK, Cheon GJ.
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1574-84. doi: 10.1007/s00259-016-3418-1. Epub 2016 May 21.Link
1917. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
Im HJ, Oo S, Jung W, Jang JY, Kim SW, Cheon GJ, Kang KW, Chung JK, Kim EE, Lee DS.
Medicine (Baltimore). 2016 May;95(19):e3686. doi: 10.1097/MD.0000000000003686.Link
1916. Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT.
Choi H, Cheon GJ, Kim HJ, Choi SH, Kim YI, Kang KW, Chung JK, Kim EE, Lee DS.
1915. Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation.
Im HJ, Paeng JC, Cheon GJ, Kim EE, Lee JS, Goo JM, Kang KW, Chung JK, Lee DS.
Nucl Med Commun. 2016 Jun;37(6):616-22. doi: 10.1097/MNM.0000000000000488.Link
1914. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
Chung HH, Kang SY, Ha S, Kim JW, Park NH, Song YS, Cheon GJ.
1913. Prognostic Implications of the SUVmax of Primary Tumors and Metastatic Lymph Node Measured by 18F-FDG PET in Patients With Uterine Cervical Cancer: A Meta-analysis.
Sarker A1, Im HJ, Cheon GJ, Chung HH, Kang KW, Chung JK, Kim EE, Lee DS.